Dr Melanie Lee to leave UCB
This article was originally published in Scrip
Dr Melanie Lee, executive vice-president of UCB and president of UCB NewMedicines, is to leave the company at the end of August to pursue other interests. Upon her departure, Dr Lee will join UCB's scientific advisory board. The company has begun its search for a new president of UCB NewMedicines.